00:00
←not started
ready
cycle —
2:00
hands-off 0:00
CCF —
shocks 0

drugs

events

H&Ts

log

    doses

    ACLS

    Epinephrine
    1 mg IV/IO q3–5 min · non-shockable: ASAP · shockable: after initial shocks fail1
    Amiodarone
    300 mg bolus → 150 mg · shock-refractory VF/pVT1
    Lidocaine
    1–1.5 mg/kg → 0.5–0.75 mg/kg · alternative to amiodarone1
    Shock
    biphasic: device default (120–200 J), unknown → max · monophasic 360 J · VF/pVT1
    Refractory VF
    vector change (AP pads) or dual sequential defibrillation — usefulness not established · shock-refractory VF1

    special circumstances

    Alteplase (PE)
    50 mg IV/IO bolus over 2 min → repeat 50 mg if no ROSC at 15 min (UpToDate) / 30 min (ERC) · suspected PE · start anticoagulation · CPR ≥60–90 min after lysis4,3,2
    Calcium chloride 10% (↑K)
    10 mL rapid IV; repeat if refractory · hyperkalaemic arrest3
    Calcium gluconate 10%
    ⅓ the Ca²⁺ per mL of chloride: 30 mL ≈ CaCl 10% 10 mL · alternative to CaCl2,3
    Sodium bicarbonate (↑K)
    50 mmol IV (separate line/flush from Ca) · hyperkalaemic arrest3
    Insulin + dextrose (↑K)
    10 U regular IV + 25 g dextrose (D50 50 mL; 50 g = 100 mL) · hyperkalaemic arrest2
    Magnesium sulfate
    2 g (8 mmol) IV over 1–2 min · torsades3
    Naloxone
    0.2–2 mg IV/IO/IM · opioid2
    Lipid emulsion 20%
    >70 kg: 100 mL over 2–3 min → 200–250 mL over 15–20 min · <70 kg: 1.5 mL/kg · local anaesthetic toxicity2
    Sodium bicarbonate (tox)
    50–150 mmol IV · Na-channel blocker (e.g. TCA)2
    Calcium chloride 10% (tox)
    20 mL IV (central preferred) · CCB / β-blocker2
    Hypothermia <30 °C
    one shock then defer; defer epinephrine until ≥30 °C · hypothermic arrest2
    1. Wigginton JG, et al. Part 9: Adult Advanced Life Support. 2025 AHA Guidelines for CPR and ECC. Circulation. 2025;152(suppl 2):S538–S577.
    2. Part 10: Adult and Pediatric Special Circumstances of Resuscitation. 2025 AHA Guidelines for CPR and ECC. Circulation. 2025;152(suppl 2):S578–S672.
    3. Lott C, Karageorgos V, et al. European Resuscitation Council Guidelines 2025: Special Circumstances in Resuscitation. Resuscitation. 2025;215:110753.
    4. UpToDate. Alteplase: Drug information — Dosing: pulmonary embolism, associated with cardiac arrest (off-label). Accessed 2026-11-12.
    end resuscitation
    transferred, CPR ongoing
    work in progress —
    confirmed
    concerns